Samchully is a leading pharmaceutical manufacturing company based on accumulated experiences in the process development for offering the pharmaceutical chemicals, especially in the field of nucleosides and its biotechnological and pharmaceutical applications. Since it抯 been established in 1983, Samchully has been working with many leading pharmaceutical and biotechnology companies, which include GlaxoSmithKline, Bristol-Myers Squibb抯, Avecia, ISIS, etc. as major customers, and offer a broad and integrated range of service for the drug development and biotechnology through marketing-scale provision. Moreover, with a devotional professionals and reliable expertise providing comfortable communication, Samchully is ready to satisfy the needs from the customers who look for the credible partner for their biotechnological and pharmaceutical development or the collaboration to grow together.